FDA Inspection
Zhejiang Haisen Pharmaceutical Co., Ltd.Zhejiang Haisen Pharmaceutical Co., Ltd. – FDA Inspection, Nov 15, 2024
Record Details
This FDA Inspection record concerns Zhejiang Haisen Pharmaceutical Co., Ltd., with an inspection on November 15, 2024, issued by the Office of Inspections and Investigations, covering human drugs.
- Inspection Date
- November 15, 2024
- Product Type
- Human Drugs
View Company Profile
ID · 9db29a92-221f-4eb6-a205-d1087d1d2756
Inspection Facts
- Inspection number
- 1255806
- FDA center
- Human Drugs
- Outcome
- Form 483 issued
Other FDA inspections of Zhejiang Haisen Pharmaceutical Co., Ltd.
3| Date | Classification | Office | Project area |
|---|---|---|---|
| April 11, 2018 | OAI | Center for Veterinary Medicine | Pre-Approval Eval. of Animal Drugs and Food Additives |
| April 21, 2017 | OAI | Center for Veterinary Medicine | Pre-Approval Eval. of Animal Drugs and Food Additives |
| December 12, 2014 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Zhejiang Haisen Pharmaceutical Co., Ltd.
- FDA Inspection 1049416 - 2018-04-11
- FDA Inspection 1013039 - 2017-04-21
- FDA Inspection 910004 - 2014-12-12
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.